BACKGROUND: Publication of complete trial results is essential if people are to be able to make well-informed decisions about health care. Selective reporting of randomised controlled trials (RCTs) is a common problem. OBJECTIVES: To systematically review studies of cohorts of RCTs to compare the content of trial reports with the information contained in their protocols, or entries in a trial registry. SEARCH STRATEGY: We conducted electronic searches in Ovid MEDLINE (1950 to August 2010); Ovid EMBASE (1980 to August 2010); ISI Web of Science (1900 to August 2010) and the Cochrane Methodology Register (Issue 3, 2010), checked reference lists, and asked authors of eligible studies to identify further studies. Studies were not excluded based ...
<div><p>Background</p><p>Most publications about selective reporting in clinical trials have focusse...
Objective: Registries are important data sources for randomised controlled trials (RCTs), but report...
Objective: To determine (i) the difference in the frequency of serious adverse events (SAEs) reporte...
CONTEXT: Selective reporting of outcomes within published studies based on the nature or direction o...
Purpose: The International Committee of Medical Journal Editors mandates trial registration as a pre...
Background: Although randomized clinical trials (RCTs) are considered the gold standard of evidence,...
International audienceBackground: Protocols are often unavailable to peer-reviewers and readers. To ...
International audienceBackground: Protocols are often unavailable to peer-reviewers and readers. To ...
International audienceBackground: Protocols are often unavailable to peer-reviewers and readers. To ...
International audienceBackground: Protocols are often unavailable to peer-reviewers and readers. To ...
International audienceBackground: Protocols are often unavailable to peer-reviewers and readers. To ...
BACKGROUND: Although randomized clinical trials (RCTs) are considered the gold standard of evidence,...
AbstractOBJECTIVES:To determine the consistency between information contained in the registration an...
AbstractOBJECTIVES:To determine the consistency between information contained in the registration an...
OBJECTIVE: Registries are important data sources for randomized controlled trials (RCTs), but report...
<div><p>Background</p><p>Most publications about selective reporting in clinical trials have focusse...
Objective: Registries are important data sources for randomised controlled trials (RCTs), but report...
Objective: To determine (i) the difference in the frequency of serious adverse events (SAEs) reporte...
CONTEXT: Selective reporting of outcomes within published studies based on the nature or direction o...
Purpose: The International Committee of Medical Journal Editors mandates trial registration as a pre...
Background: Although randomized clinical trials (RCTs) are considered the gold standard of evidence,...
International audienceBackground: Protocols are often unavailable to peer-reviewers and readers. To ...
International audienceBackground: Protocols are often unavailable to peer-reviewers and readers. To ...
International audienceBackground: Protocols are often unavailable to peer-reviewers and readers. To ...
International audienceBackground: Protocols are often unavailable to peer-reviewers and readers. To ...
International audienceBackground: Protocols are often unavailable to peer-reviewers and readers. To ...
BACKGROUND: Although randomized clinical trials (RCTs) are considered the gold standard of evidence,...
AbstractOBJECTIVES:To determine the consistency between information contained in the registration an...
AbstractOBJECTIVES:To determine the consistency between information contained in the registration an...
OBJECTIVE: Registries are important data sources for randomized controlled trials (RCTs), but report...
<div><p>Background</p><p>Most publications about selective reporting in clinical trials have focusse...
Objective: Registries are important data sources for randomised controlled trials (RCTs), but report...
Objective: To determine (i) the difference in the frequency of serious adverse events (SAEs) reporte...